DEUTSCHE BANK AG\ - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 93 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$89,000
-63.8%
23,276
-75.7%
0.00%
Q1 2021$246,000
-6.8%
95,606
-9.4%
0.00%
Q4 2020$264,000
+23.4%
105,583
+2.0%
0.00%
Q3 2020$214,000
+1.4%
103,512
+52.4%
0.00%
Q2 2020$211,000
+56.3%
67,904
+14.0%
0.00%
Q1 2020$135,000
-69.5%
59,556
-51.5%
0.00%
Q4 2019$443,000
+751.9%
122,724
+683.6%
0.00%
Q3 2019$52,000
-70.3%
15,661
-58.1%
0.00%
Q2 2019$175,000
-31.9%
37,400
-51.4%
0.00%
Q1 2019$257,000
-49.1%
77,001
-59.5%
0.00%
Q4 2018$505,000
-68.0%
190,266
-32.5%
0.00%
Q3 2018$1,578,000
+52.9%
282,067
+38.4%
0.00%
Q2 2018$1,032,000
-21.3%
203,741
+5.9%
0.00%
-100.0%
Q1 2018$1,311,000
+0.1%
192,323
+10.8%
0.00%0.0%
Q4 2017$1,310,000
+264.9%
173,580
+176.9%
0.00%
Q3 2017$359,000
+81.3%
62,690
+58.9%
0.00%
Q2 2017$198,000
+17.2%
39,463
-39.6%
0.00%
Q1 2017$169,000
+168.3%
65,337
+88.5%
0.00%
Q3 2016$63,00034,6580.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 5,628,585$5,853,7285.06%
Aquilo Capital Management, LLC 4,552,876$4,734,9911.78%
BVF INC/IL 5,080,320$5,283,5330.22%
Soleus Capital Management, L.P. 1,000,000$1,040,0000.15%
Cutter & CO Brokerage, Inc. 378,479$393,6180.13%
PLATINUM INVESTMENT MANAGEMENT LTD 1,220,798$1,269,6300.05%
GSA CAPITAL PARTNERS LLP 365,047$3800.05%
Annandale Capital, LLC 67,000$700.02%
WEALTH EFFECTS LLC 21,700$22,5680.01%
Sigma Planning Corp 343,934$357,6910.01%
View complete list of PIERIS PHARMACEUTICALS INC shareholders